The DOI matches its Crossref record; 144 of the 145 references it cites were found in a registry or an index.
Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
Open accessAbstract
Cardio-obstetrics has emerged as an important multidisciplinary field that requires a team approach to the management of cardiovascular disease during pregnancy. Cardiac conditions during pregnancy include hypertensive disorders, hypercholesterolemia, myocardial infarction, cardiomyopathies, arrhythmias, valvular disease, thromboembolic disease, aortic disease, and cerebrovascular diseases. Cardiovascular disease is the primary cause of pregnancy-related mortality in the United States. Advancing maternal age and preexisting comorbid conditions have contributed to the increased rates of maternal mortality. Preconception counseling by the multidisciplinary cardio-obstetrics team is essential for women with preexistent cardiac conditions or history of preeclampsia. Early involvement of the cardio-obstetrics team is critical to prevent maternal morbidity and mortality during the length of the pregnancy and 1 year postpartum. A general understanding of cardiovascular disease during pregnancy should be a core knowledge area for all cardiovascular and primary care clinicians. This scientific statement provides an overview of the diagnosis and management of cardiovascular disease during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Support from an interdisciplinary team that may include nutritionists, kinesiologists, pharmacists, and mental health specialists, in addition to obesity medicine specialists, can be particularly effective for facilitating lifestyle modification and weight loss.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More timely initiation of therapy is associated with improved cardiovascular clinical outcomes among individuals with hypertension, diabetes, and dyslipidemias.18,53”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent evidence suggests that counseling related to risk reduction for CKM syndrome in high-risk women should start in the prenatal period and continue until the completion of postpartum follow-up visits for the mother and baby.16–18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the lack of CVD event reduction, lifestyle modification with behavior change, healthy dietary modification, and physical activity, resulting in weight loss of 5% to 10%, causes improvements in CKM risk factors including remission of T2D,17,18 with the CKM benefits of lifestyle modification observed across a range of populations and geographic settings.19”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dysregulation of these changes leading to excess insulin resistance, adipose deposition, hypercoagulability, cardiac remodeling, and decreased vascular resistance,12,18 may result in APOs.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adverse CKM risk factor levels (overweight/obesity, hypertension, hypertriglyceridemia, diabetes, CKD) during the prepregnancy period are associated with increased risk of APOs.18,29”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While waist-hip ratio provides improved characterization of metabolic and cardiovascular risk than waist circumference, challenges of complexity of measurement and lack of standardization make it less ideal for use in clinical settings.18,29–32”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Using both BMI and waist circumference provides complementary prognostic information regarding risk for future metabolic derangements, incident CVD, and mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Regular assessments of lipids, glycemia, and kidney function (eg, eGFR) are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.13,18–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Through these mechanisms, adverse SDOH lead to CKM risk factor development.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Modest weight loss of 5% to 10% among patients with overweight or obesity and diabetes is associated with improvement in glycemic measures, BP, HDL-C, and triglycerides, among others. This can result in risk reduction for incident CKM risk factors such as diabetes and hypertension.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Average excess weight loss is greater with RYGB (56%) than LSG (46%),2,18 with persistent differences at 10 years.4”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Bupropion/naltrexone, phentermine/topiramate, and orlistat have all shown efficacy in improving glycemia, and the latter 2, in reducing BP.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Clinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.17–19,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In patients with symptomatic PAD, semaglutide increases walking distance.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Treatment of obesity-related HFpEF with the GLP-1–based therapies semaglutide and tirzepatide achieves improvements in HF patient-reported health status and quality of life, functional capacity as measured by the 6-minute walk distance (6MWD), and freedom from worsening HF events, including HF hospitalizations.1,3,17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One analysis was based on the results of the EMPEROR-PRESERVED trial, in which the effect of SLGT2i on cardiovascular mortality in HFpEF was not statistically significant (HR, 0.91; 95% CI, 0.76–1.09).”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Two high-quality simulation model–based cost-effectiveness analyses evaluated the economic value of adding SGLT2i therapy to prior GDMT in adults with symptomatic HFpEF, but neither study reported subgroup analyses by diabetes status.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a sensitivity analysis assuming a 9% cardiovascular mortality benefit, the ICER was $174 053 per QALY gained.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Prior studies performed using a US health care sector perspective and a lifetime analytic horizon noted that SGLT2i therapy was unlikely to be cost-effective for HFpEF, but that the incremental cost-effectiveness ratio was sensitive to the effect on mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These analyses suggest that SGLT2i therapy is not cost-effective at current drug prices (incremental cost-effectiveness ratio ≥$120 000 per QALY gained), but these analyses pooled individuals with and without diabetes, and there may be additional cardiovascular and kidney benefits in individuals with diabetes.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fibrosis stage best predicts adverse outcomes in MASLD.1,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“a lower eGFR, higher UACR, and higher CKD stages are associated with VTE development and worse outcomes.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Women planning pregnancy with diabetes are at greater risk of experiencing APOs compared to women without diabetes or those who develop GDM.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“An effective response to obesity pharmacotherapy has historically been described as at least 5% of body weight loss after 3 months of treatment.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“MBS, which induces body weight loss of >20%, also improves OSA, and is associated with reductions in CV and renal events, and in cardiovascular and all-cause mortality among people with OSA.3,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C.-T., Fesmire, F. M., Franklin, B. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,797
Erbel (2014) · doi:10.1093/eurheartj/ehu281 · Cited by 4,451
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,920
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544
WRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,346
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
Ferro, J. M., Canhão, P., Stam, J., Bousser, M., & Barinagarrementería, F. (2004) · Stroke · doi:10.1161/01.str.0000117571.76197.26 · Cited by 2,309
Research works printed but not linked: 2
- Martin, JA, Hamilton, BE, Osterman, MJK, Driscoll, AK, Drake, P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67:1–50.
- 10.1136/hrt.2006.095240 · DOI
Cited by
Sorted by citations
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,395
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis‐Holland, J. E., Bangalore, S., Bates, E., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,691
Self-citationVirani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Lawton, J. S., Tamis‐Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 1,349
Self-citationPreeclampsia—Pathophysiology and Clinical Presentations
Ives, C. W., Sinkey, R. G., Rajapreyar, I. N., Tita, A., & Oparil, S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.014 · Cited by 934
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac106 · Cited by 538
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A. D., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001285 · Cited by 435
Menopause: a cardiometabolic transition
Nappi, R. E., Chedraui, P., Lambrinoudaki, I. V., & Simoncini, T. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00076-6 · Cited by 283
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A. D., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.013 · Cited by 257
Lewey, J., Beckie, T. M., Brown, H. L., Brown, S. D., Garovic, V. D., Khan, S. S., Miller, E. C., Sharma, G., Mehta, L. S., & on behalf of the American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, C. C. (2024) · Circulation · doi:10.1161/cir.0000000000001212 · Cited by 229
Self-citation2023 Chinese guideline for lipid management
Li, J., Zhao, S., Zhao, D. H., Lü, G., Peng, D., Liu, J., Chen, Z., Guo, Y., Wu, N., Yan, S.-K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1190934 · Cited by 232
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 236
Mehta, L. S., Velarde, G., Lewey, J., Sharma, G. V., Bond, R. M., Navas‐Acién, A., Fretts, A. M., Magwood, G., Yang, E., Blumenthal, R. S., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001139 · Cited by 202
Self-citationSex Differences and Similarities in Valvular Heart Disease
DesJardin, J. T., Chikwe, J., Hahn, R. T., Hung, J., & Delling, F. N. (2022) · Circulation Research · doi:10.1161/circresaha.121.319914 · Cited by 192
Davis, M. B., Arendt, K. W., Bello, N. A., Brown, H. L., Briller, J. E., Epps, K., Hollier, L. M., Langen, E. S., Park, K. E., Walsh, M. N., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.033 · Cited by 192
Self-citation2023 HRS expert consensus statement on the management of arrhythmias during pregnancy
Joglar, J. A., Kapa, S., Saarel, E. V., Dubin, A. M., Görenek, B., Hameed, A. B., de Melo, S. L., Leal, M. A., Mondesert, B. A., Pacheco, L. D., et al. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.05.017 · Cited by 169
Mehta, L. S., Sharma, G. V., Creanga, A. A., Hameed, A. B., Hollier, L. M., Johnson, J. C., Leffert, L. R., McCullough, L. D., Mujahid, M. S., Watson, K. E., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001000 · Cited by 136
Self-citation2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
Gurvitz, M. Z., Krieger, E. V., Fuller, S., Davis, L. L., Kittleson, M. M., Aboulhosn, J., Bradley, E. A., Buber, J., Daniels, C. J., Dimopoulos, K., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.006 · Cited by 138
Self-citationCardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America
Bloom, M. W., Vo, J. B., Rodgers, J. E., FERRARI, A. M., Nohria, A., Deswal, A. M., Cheng, R. K.-H., Kittleson, M. M., Upshaw, J. N., Palaskas, N. L., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.08.045 · Cited by 125
Meng, M., Arendt, K. W., Banayan, J. M., Bradley, E. A., Vaught, A. “. J., Hameed, A. B., Harris, J., Bryner, B. S., & Mehta, L. S. (2023) · Circulation · doi:10.1161/cir.0000000000001121 · Cited by 119
Self-citation2023 China Guidelines for Lipid Management
Li, J., Zhao, S., Zhao, D., Lü, G., Peng, D., Liu, J., Chen, Z., Guo, Y., Wu, N., Yan, S.-K., et al. (2023) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2023.09.008 · Cited by 120
Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations
Meng, M., & Arendt, K. W. (2021) · Anesthesiology · doi:10.1097/aln.0000000000003833 · Cited by 98
Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools
Adedinsewo, D. A., Pollak, A. W., Phillips, S. D., Smith, T. L., Svatikova, A., Hayes, S. N., Mulvagh, S. L., Norris, C., Roger, V. L., Noseworthy, P. A., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319876 · Cited by 95
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Pre-Pregnancy Hypertension Among Women in Rural and Urban Areas of the United States
Cameron, N. A., Molsberry, R. J., Pierce, J. B., Perak, A. M., Grobman, W. A., Allen, N. B., Greenland, P., Lloyd‐Jones, D. M., & Khan, S. S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.601 · Cited by 88
Hyperlipidemia and risk for preclampsia
Poornima, I. G., Indaram, M. B., Ross, J. D., Agarwala, A., & Wild, R. A. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.02.005 · Cited by 86
ACC/AHA/HFSA 2022 and ESC 2021 Guidelines on Heart Failure Comparison
Behnoush, A. H., Khalaji, A., Naderi, N., Ashraf, H., & von Haehling, S. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14255 · Cited by 92
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 97
Cardiovascular Care for Pregnant Women With Cardiovascular Disease
Magun, E., DeFilippis, E. M., Noble, S. C., LaSala, A. P., Waksmonski, C. A., D’Alton, M. E., & Haythe, J. H. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.071 · Cited by 81
Dyslipidaemia management in pregnant patients: a 2024 update
Lewek, J., Bielecka-Dabrowa, A. M., Toth, P. P., & Banach, M. (2024) · European Heart Journal Open · doi:10.1093/ehjopen/oeae032 · Cited by 77
Reproductive health after thoracic transplantation: An ISHLT expert consensus statement
Kittleson, M. M., DeFilippis, E. M., Bhagra, C., Casale, J. P., Cauldwell, M., Coscia, L. A., D'Souza, R. D., Gaffney, N., Gerovasili, V., Ging, P., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.009 · Cited by 67
Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010–19
Majmundar, M. M., Doshi, R. P., Patel, K. N., Zala, H. S., Kumar, A., & Kalra, A. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac669 · Cited by 64
Pregnancy-Associated Myocardial Infarction
Tweet, M. S., Lewey, J., Smilowitz, N. R., Rose, C. H., & Best, P. J. M. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.008687 · Cited by 64
Cardiovascular adverse events in pregnancy: A global perspective
Kotit, S., & Yacoub, M. H. (2021) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2021.5 · Cited by 65
Eke, A. C., Gebreyohannes, R. D., Fernandes, M. F. S., & Pillai, V. C. (2023) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2227 · Cited by 65
Agarwala, A., Dixon, D. L., Gianos, E., Kirkpatrick, C. F., Michos, E. D., Satish, P., Birtcher, K. K., Braun, L. T., Pillai, P., Watson, K., et al. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.05.005 · Cited by 57
Self-citationBright, R. A., Lima, F. V., Avila, C., Butler, J., & Stergiopoulos, K. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021019 · Cited by 58
Valvular Heart Disease in Pregnancy
Lewey, J., Andrade, L., & Levine, L. D. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.09.010 · Cited by 58
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 52
Sex and Gender Aspects in Vascular Ageing – Focus on Epidemiology, Pathophysiology, and Outcomes
Seeland, U., Nemcsik, J., Lønnebakken, M. T., Kublickiene, K. R., Schluchter, H., Park, C. M., Pucci, G., Mozos, I. M., & Bruno, R. M. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.07.006 · Cited by 47
Adedinsewo, D. A., Johnson, P. W., Douglass, E. J., Attia, I. Z., Phillips, S. D., GOSWAMI, R. M., Yamani, M. H., Connolly, H. M., Rose, C. H., Sharpe, E. E., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab078 · Cited by 46
Roh, J. D., Castro, C., Yu, A., Rana, S., Shahul, S. S., Gray, K. J., Honigberg, M. C., Ricke‐Hoch, M., Iwamoto, Y., Yeri, A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0077 · Cited by 44
Self-citationKris-Etherton, P. M., Petersen, K. S., Després, J.-P., Braun, L., de Ferranti, S. D., Furie, K. L., Lear, S. A., Lobelo, F., Morris, P. B., Sacks, F. M., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001014 · Cited by 43
Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025
Rached, F. H., Miname, M. H., Rocha, V. Z., Zimerman, A., Cesena, F. Y., Sposito, A. C., Santos, R. D., Behr, P. E. B., Bianco, H. T., Alves, R. J., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250640 · Cited by 50
Echocardiography for the Pregnant Heart
Afari, H. A., Davis, E., & Sarma, A. A. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00930-5 · Cited by 43
Management of acute cardiovascular complications in pregnancy
Assenza, G. E., Dimopoulos, K., Budts, W., Donti, A., Economy, K. E., Gargiulo, G., Gatzoulis, M. Α., Landzberg, M. J., Valente, A. M., & Roos‐Hesselink, J. W. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab546 · Cited by 42
Self-citationWindram, J. D., Grewal, J., Bottega, N. A., Sermer, M., SPEARS, D. A., Swan, L., Siu, S. C., & Silversides, C. K. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.06.021 · Cited by 42
Gurvitz, M. Z., Krieger, E. V., Fuller, S., Davis, L. L., Kittleson, M. M., Aboulhosn, J., Bradley, E. A., Buber, J., Daniels, C. J., Dimopoulos, K., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001402 · Cited by 38
Self-citationThe Fourth Trimester: a Time for Enhancing Transitions in Cardiovascular Care
Choi, E., Kazzi, B. E., Varma, B., Ortengren, A. R., Minhas, A., Vaught, A. “. J., Bennett, W. L., Lewey, J., & Michos, E. D. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00706-x · Cited by 37
Long‐Term Cardiovascular Outcomes After Pregnancy in Women With Heart Disease
Siu, S. C., Lee, D. S., Rashid, M. K., Fang, J., Austin, P. C., & Silversides, C. K. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020584 · Cited by 38
D’Antonio, F., Khalil, A. A., Rizzo, G., Fichera, A., Herrera, M., Buca, D. I. P., Morelli, R., Cerra, C., Orabona, R., Martellucci, C. A., et al. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100803 · Cited by 35
Briller, J. E., Mogos, M. F., Muchira, J. M., & Piano, M. R. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.12.020 · Cited by 35
Extracorporeal Membrane Oxygenation for Pregnant and Postpartum Patients
Wong, M. J., Bharadwaj, S., Galey, J. L., Lankford, A. S., Galvagno, S. M., & Kodali, B. S. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005861 · Cited by 34
Worldwide variation in cardiovascular magnetic resonance practice models
Sierra-Galán, L. M., Estrada-Lopez, E. E. S., Ferrari, V. A., Raman, S. V., Ferreira, V. M., Raj, V., Joseph, E., Schulz‐Menger, J., Chan, C., Chen, S. S. M., et al. (2023) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-023-00948-7 · Cited by 33
Ogunwole, S. M., Chen, X., Mitta, S., Minhas, A., Sharma, G. V., Zakaria, S., Vaught, A. “. J., Toth‐Manikowski, S. M., & Smith, G. N. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.08.004 · Cited by 33
Self-citationPregnancy after Heart Transplantation
DeFilippis, E. M., & Kittleson, M. M. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.07.011 · Cited by 32
Perfil Epidemiológico da Mortalidade Materna por Síndromes Hipertensivas Gestacionais
Santos, I. D. M., & Almeida-Santos, M. A. (2023) · Research Society and Development · doi:10.33448/rsd-v12i4.41307 · Cited by 30
Leszek, P., Klotzka, A., Bartuś, S., Burchardt, P., Czarnecka, A. M., Długosz‐Danecka, M., Gierlotka, M. J., Koseła-Paterczyk, H., Krawczyk‐Ożóg, A., Kubiatowski, T., et al. (2023) · Kardiologia Polska · doi:10.33963/v.kp.96840 · Cited by 31
Posicionamento sobre Exercícios Físicos na Gestação e no Pós-Parto – 2021
Campos, M. D. S. B., Buglia, S., Colombo, C. S. S. D. S., Büchler, R. D. D., de Brito, A. S. X., Mizzaci, C. C., Feitosa, R. H. F., Leite, D. B., Hossri, C. A. C., de Albuquerque, L. C. A., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210408 · Cited by 32
Bello, N. A., Agrawal, A., Davis, M. B., Harrington, C. M., Lindley, K. J., Minissian, M., Sharma, G. V., Walsh, M. N., & Park, K. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024229 · Cited by 30
Self-citationImaging of heart disease in women: review and case presentation
Mikaïl, N., Rossi, A., Bengs, S., Haider, A., Stähli, B. E., Portmann, A., Impériale, A., Treyer, V., Meisel, A., Pazhenkottil, A. P., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05914-6 · Cited by 30
Thromboembolism in peripartum cardiomyopathy: a systematic review
Radakrishnan, A., Dokko, J., Pastena, P., & Kalogeropoulos, A. P. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-945 · Cited by 27
Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
Thakkar, A., Hailu, T., Blumenthal, R. S., Martin, S. S., Harrington, C. M., Yeh, D. D., French, K. A., & Sharma, G. V. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01026-6 · Cited by 27
Self-citationMaternal Morbidity and Mortality: Are We Getting to the “Heart” of the Matter?
Varagić, J., Desvigne-Nickens, P. M., Gamble‐George, J., Hollier, L. M., Maric‐Bilkan, C., Mitchell, M., Pemberton, V. L., & Redmond, N. (2020) · Journal of Women s Health · doi:10.1089/jwh.2020.8852 · Cited by 25
Pregnancy-Associated Myocardial Infarction: A Review of Current Practices and Guidelines
Alameh, A., Jabri, A., Aleyadeh, W., Nasser, F., Al‐Abdouh, A., Kondapaneni, M. D., Gulati, M., Mattina, D. J., Singh, K., Hargrave, J. M., et al. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01579-z · Cited by 25
Trends in the Incidence and Risk Factors of Pregnancy-Associated Stroke
Ijäs, P. H. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.833215 · Cited by 27
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies
Parashar, S., Akhter, N., Paplomata, E., Elgendy, I. Y., Upadhyaya, D., Scherrer‐Crosbie, M., Okwuosa, T. M., Sanghani, R. M., Chalas, E., Lindley, K. J., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.02.002 · Cited by 26
Boriani, G., Venturelli, A., Imberti, J. F., Bonini, N., Mei, D. A., & Vitolo, M. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.04.020 · Cited by 25
Enomoto, N., Yamashita, T., Furuta, M., Tanaka, H., Ng, E. S. W., Matsunaga, S., Sakurai, A., Kato, R., Takahashi, S., Takeda, J., et al. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04334-y · Cited by 24
Cardiovascular contributions to dementia: Examining sex differences and female‐specific factors
Alexander, M. W., Paterson, J., Arvanitakis, Z., Black, S. E., Casaletto, K. B., Christakis, M. K., Einstein, G., Galea, L. A. M., Harwood, L., Kirkham, A. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70610 · Cited by 23
Steiner, J. M., Lokken, E. M., Bayley, E., Pechan, J., Curtin, A. C., Buber, J., & Albright, C. M. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.08.037 · Cited by 23
Denoble, A. E., Goldstein, S. A., Wein, L. E., Grotegut, C. A., & Federspiel, J. J. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.04.009 · Cited by 23
Assessment and Prediction of Cardiovascular Contributions to Severe Maternal Morbidity
Thakkar, A., Hameed, A. B., Makshood, M., Gudenkauf, B., Creanga, A. A., Malhamé, I., Grandi, S. M., Thorne, S., D'Souza, R. D., & Sharma, G. V. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100275 · Cited by 23
Self-citationPark, S. M., Lee, S. Y., Jung, M., Youn, J., Kim, D., Cho, J. Y., Cho, D., Hyun, J., Cho, H., Park, S., et al. (2023) · International Journal of Heart Failure · doi:10.36628/ijhf.2023.0016 · Cited by 21
Reproductive milestones across the lifespan and cardiovascular disease risk in women
Stuenkel, C. A. (2023) · Climacteric · doi:10.1080/13697137.2023.2259793 · Cited by 21
Complementary medicines and therapies in clinical guidelines on pregnancy care: A systematic review
Ee, C., Levett, K. M., Smith, C. A., Armour, M., Dahlen, H. G., Chopra, P., Maroun, P., Rao, V. S., Avard, N., Grant, S., et al. (2021) · Women and Birth · doi:10.1016/j.wombi.2021.08.003 · Cited by 22
Maternal Cardiovascular Morbidity Events Following Preeclampsia: A Retrospective Cohort Study
Meng, M., Frere, Z., Fuller, M., Li, Y., Habib, A. S., Federspiel, J. J., Wheeler, S. M., Gilner, J. B., Shah, S. H., Ohnuma, T., et al. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006310 · Cited by 20
Perioperative management of pregnant women undergoing nonobstetric surgery
Aurón, M., Castillo, M. Y. D., & Dueñas-García, O. F. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.18111 · Cited by 20
Shara, N. M., Mirabal‐Beltran, R., Talmadge, B., Falah, N. U., Ahmad, M. F., Dempers, R., Crovatt, S., Eisenberg, S. B., & Anderson, K. M. (2024) · JMIR Cardio · doi:10.2196/53091 · Cited by 20
Animal Models of Cardiovascular Complications of Pregnancy
Arany, Z. P., Hilfiker‐Kleiner, D., & Karumanchi, S. A. (2022) · Circulation Research · doi:10.1161/circresaha.122.320395 · Cited by 19
Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review
Yaghoobpoor, S., Fathi, M., Vakili, K. G., Tutunchian, Z., Dehghani, M., Bahrami, A., Hajibeygi, R., Eslami, S., Yaghoobpour, T., & Hajiesmaeili, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206194 · Cited by 20
Adedinsewo, D. A., Morales-Lara, A. C., Dugan, J. L., Garzon-Siatoya, W. T., Yao, X., Johnson, P. W., Douglass, E. J., Attia, Z. I., Phillips, S. D., Yamani, M. H., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.03.008 · Cited by 19
Preeclampsia: Etiology, Pathophysiology, Risk Factors, Impact and Prevention: A Narrative Review
Mustary, M., Ansariadi, A., Syam, A., Riskiyani, S., Erika, K. A., Moedjiono, A. I., & Lubis, M. (2024) · Iranian Journal of Public Health · doi:10.18502/ijph.v53i11.16941 · Cited by 20
Sierra-Galán, L. M., Bhatia, M., Alberto-Delgado, A. L., Madrazo-Shiordia, J. A., Salcido-Carmona, C. A., Santoyo, B., Martinez, E., & Soto, M. E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870200 · Cited by 19
Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review
Girolamo, R. D., Alameddine, S., Khalil, A. A., Santilli, F., Rizzo, G., Maruotti, G. M., Liberati, M., & D’Antonio, F. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.12.032 · Cited by 18
Rakisheva, A., Sliwa, K. S., Bauersachs, J. K., Linthout, S. V., Chopra, V., Bayés‐Genís, A., Fruzzetti, F., Cannata, A. N., Deniau, B., Mebazaa, A., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3246 · Cited by 19
Interventional Cardiac Procedures and Pregnancy
Park, K. E., Bortnick, A. E., Lindley, K. J., Sintek, M. A., Sethi, S. S., Choi, C., Davis, M. B., Walsh, M. N., Voeltz, M. D., Bello, N. A., et al. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100427 · Cited by 17
Garcia, J. E., Mulrenin, I. R., Nguyen, A. B., Loop, M. S., Daubert, M. A., Urrutia, R. P., & Lee, C. R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1225251 · Cited by 18
Acute Coronary Syndrome in Pregnancy and the Post-Partum Period
O’Kelly, A. C., Ludmir, J., & Wood, M. J. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9070198 · Cited by 18
Self-citationRex, S., & Devroe, S. (2022) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2022.02.005 · Cited by 16
Assessing the dyslipidemias: to fast or not to fast?
Farukhi, Z. M., & Mora, S. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000615 · Cited by 16
Mulrenin, I. R., Garcia, J. E., Fashe, M. M., Loop, M. S., Daubert, M. A., Urrutia, R. P., & Lee, C. R. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.2002845 · Cited by 16
Substance Use in Pregnancy and its Association With Cardiovascular Events
Evans, K., Wu, P., Mamas, M. A., Irwin, C., Kang, P. T., Perlow, J. H., Foley, M., & Gulati, M. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100619 · Cited by 16
Pregnancy, aortic events, and neonatal and maternal outcomes
Chen, S., Chang, F., Chen, C.-Y., Cheng, Y.-T., Hsiao, F., Tung, Y., Lin, C., Wu, V. C., Chu, P., & Chou, A. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae757 · Cited by 16
Ghelfi, A. M., Ferretti, M. V., & Staffieri, G. J. (2021) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2021.01.002 · Cited by 16
Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease
Thobani, A., Hassen, L. J., Mehta, L. S., & Agarwala, A. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00957-w · Cited by 16
Self-citationReproductive Health in Congenital Heart Disease: Preconception, Pregnancy, and Postpartum
Halpern, D. G., Penfield, C. A., Feinberg, J. L., & Small, A. J. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10050186 · Cited by 16
Metadata
- Authors
- Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., Safdar, B., Sharma, G., Wood, M., Valente, A. M., Volgman, A. S., & On behalf of the American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. S. C.
- ORCID
- Venue
- Circulation
- Published
- 2020-06-09
- Volume
- 141
- Issue
- 23
- Pages
- e884-e903
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3022591273
- Semantic Scholar
- a4f99c537a938a755723900351845a99644d8796
- Cited by
- 464
- References
- 145
- Citations by year
- 2026: 96 · 2025: 69 · 2024: 70 · 2023: 81 · 2022: 75 · 2021: 56 · 2020: 17
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Issues in Pregnancy
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- cardiovascular disease in pregnancy, cardio-obstetrics, maternal mortality, hypertensive disorders of pregnancy, preeclampsia, hypercholesterolemia, myocardial infarction, cardiomyopathy, cardiac arrhythmias, valvular heart disease, thromboembolism, aortic disease, cerebrovascular disease, preconception counseling, maternal morbidity, postpartum care
- MeSH terms
- American Heart Association, Female, Humans, Postnatal Care, Pregnancy, Pregnancy Complications, Cardiovascular, United States, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
